{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for methyl root_references_citation in Reference Text / Citation (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2002)
Source URL:
First approved in 1990
Source:
NDA019927
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NataFort by Mission Pharmacal Company
(2011)
Source URL:
First approved in 1988
Source:
NDA019569
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Lowila Care by RANBAXY LABORATORIES INC.
(2010)
Source URL:
First approved in 1985
Source:
NDA211321
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020353
(1976)
Source URL:
First approved in 1976
Source:
NDA020353
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M004
(2010)
Source URL:
First approved in 1971
Source:
ANDA215609
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03365336: Not Applicable Interventional Unknown status Influenza
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT00936624: Phase 2 Interventional Completed Asthma
(2009)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
